相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
S. M. Garonzik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetic evaluation of colistin sodium
Argyris S. Michalopoulos et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Risk factors for colistin-associated nephrotoxicity
Pinyo Rattanaumpawan et al.
JOURNAL OF INFECTION (2011)
Early Acute Kidney Injury Is a Risk Factor That Predicts Mortality in Patients Treated with Colistin
Hee ja Ko et al.
NEPHRON CLINICAL PRACTICE (2011)
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
Roberto Imberti et al.
CHEST (2010)
Predictors of acute kidney injury associated with intravenous colistin treatment
Jeong-Ah Kwon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
Chien-Yu Cheng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Serum Bactericidal Activity of Three Different Dosing Regimens of Colistin with Implications for Optimum Clinical Use
G. L. Daikos et al.
JOURNAL OF CHEMOTHERAPY (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell et al.
CLINICAL INFECTIOUS DISEASES (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit
Andrew F. Shorr
CRITICAL CARE MEDICINE (2009)
The changing epidemiology of resistance
Peter M. Hawkey et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Teresa C. Horan et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
N. Petrosillo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients
Sean M. Bagshaw et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally
George L. Drusano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Back to the future: Using Aminoglycosides again and how to dose them optimally
George L. Drusano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study
H. Kallel et al.
INTENSIVE CARE MEDICINE (2007)
Does this patient have ventilator-associated pneumonia?
Michael Klompas
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria
M. E. Falagas et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Nephrotoxicity of intravenous colistin: a prospective evaluation
ME Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections:: a prospective cohort study
R Reina et al.
INTENSIVE CARE MEDICINE (2005)
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis
SK Kasiakou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
AS Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Colistin interactions with the mammalian urothelium
JR Lewis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
N Markou et al.
CRITICAL CARE (2003)
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP
J Garnacho-Montero et al.
CLINICAL INFECTIOUS DISEASES (2003)
Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa
PK Linden et al.
CLINICAL INFECTIOUS DISEASES (2003)
Goodpasture syndrome during the course of a Schonlein-Henoch purpura:
L Carreras et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
分享论文
